AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2018
Jul 31, 2018
30136_dirs_2018-07-31_b5061001-6d14-420b-8ab3-20ecb63f6eef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2018-07-27
Reporting Person: KELLEY JOHN J III (Chief Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-07-27 | Common Stock | A | 4049.0000 | $0.0000 | Acquired | 23109.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-27 | Stock Option/Right to Buy | $123.4900 | A | 16196.0000 | Acquired | 2028-07-27 | Common Stock (16196.0000) | Direct |
Footnotes
F1: Special equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 7/27/2021.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3: Special equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 7/27/2019.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26